By Dennis Thompson HealthDay Reporter THURSDAY, Oct. 24, 2024 (HealthDay News) -- Expanding access to cutting-edge diabetes ...
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...
Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, ...
U.S. health insurance claims analysis shows that two years after starting Novo Nordisk's Wegovy or similar GLP-1 drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback